skip to navigation skip to content
Search

pharmaceuticals

Carryover co-operation

Sir Mene Pangalos of AstraZeneca, in a Cambridge Judge interview, urges continuation of the 'exceptional' collaboration between industry, academia, government and regulators that led to rapid development of COVID-19 vaccines. Sir Mene Pangalos The "exceptional" collaboration between the pharmaceutical industry,…

Read more

Female scientist looking at ampoule with new medication, vaccination development.

Biopharm expansion

Apollo Therapeutics, a life sciences company led by Cambridge Judge Business School alumnus and Fellow Dr Richard Mason, completes $145 million financing. Apollo Therapeutics, a biopharmaceutical company headed by Cambridge Judge Business School MBA alumnus and Fellow Dr Richard Mason…

Read more

Scientists working in a modern laboratory.

United Press International: Study: Second opinion can reduce risk for long-term opioid use

A study looking at opioid use co-authored by Stefan Scholtes, Dennis Gillings Professor of Health Management at Cambridge Judge Business School, featured in United Press International. The study found that “a “second opinion” by another prescribing doctor within 30 days…

Read more

Opioid intervention

'Second opinion' by another prescribing doctor within 30 days of an opioid prescription reduces long-term opioid use by 31%, concludes a new study led at Cambridge Judge Business School. A "second opinion" by another prescribing doctor within 30 days of…

Read more

High angle view of a prescription bottled filled with pills surrounded by more of the same tablets, with copy space,

Stock sales

Three US senators cite research by Professor Alan Jagolinzer of Cambridge Judge Business School in urging SEC reform of insider trading laws.  Professor Alan Jagolinzer Three US senators cited research co-authored by Professor Alan Jagolinzer of Cambridge Judge Business School in urging the Securities…

Read more

Woman tracking and trading stocks using laptop and desktop computer. Stock Exchange, investment, and financial trading concept.

Good reporting

Annual reports should inform society – not just shareholders – about vital issues such as the financial health and environmental impact of organisations, says Professor Alan Jagolinzer of Cambridge Judge Business School. Professor Alan Jagolinzer By Professor Alan Jagolinzer Corporate…

Read more

Business people discussing an annual report.

Forbes India: How drug companies can increase their R&D effectiveness

A study co-authored by Professor Stylianos Kavadias and Dr Nektarios Oraiopoulos at University of Cambridge Judge Business School, is featured in the Forbes article. The study demonstrates “how pharmaceutical executives can impact the success of their research and development” programs…

Read more

Call for SEC action

Article co-authored by Professor Alan Jagolinzer of Cambridge Judge calls for Securities and Exchange Commission to reform 'pre-planned' stock sale rules. Professor Alan Jagolinzer An article co-authored by Professor Alan Jagolinzer of Cambridge Judge Business School in The Hill, a…

Read more

Business person using tablet and analysing stock exchange online in monitoring room background, forex trading graph, stock market and financial investment concept.

Cambridge Network: Study examines cultural fit in big pharma integration

Piyush Durani, an Executive MBA graduate of Cambridge Judge (EMBA 2018), measures cultural fit in the $74 billion merger of Bristol-Myers Squibb and Celgene. “As I progressed through my EMBA programme in 2018-2019, the BMS acquisition of Celgene was announced…

Read more

Big pharma

Piyush Durani, an Executive MBA graduate of Cambridge Judge (EMBA 2018), measures cultural fit in the $74 billion merger of Bristol-Myers Squibb and Celgene. Piyush Durani The well-known business expression "culture eats strategy for breakfast" is particularly apt for mergers…

Read more

Cartoon of two business people discussing a pharmaceutical capsule.

Archives